| http://www.w3.org/ns/prov#value | - ?s Cardiogenesis business may be negatively impacted, in the future, the FDA could restrict the current uses of Cardiogenesis??? TMR System and thereby restrict its ability to generate revenues, CryoLife may fail to comply with international regulatory requirements with respect to Cardiogenesis??? business and could be subject to regulatory delays, fines or other penalties, CryoLife will continue
|
